Cheng‐Yi Wang

4.2k citations
88 papers · 2.7k indexed · 1 hit paper · h-index 23

Impact in

Papers in

    • Chronic Obstructive Pulmonary Disease (COPD) Research 17
    • Respiratory Support and Mechanisms 15
    • Inhalation and Respiratory Drug Delivery 7
    • Lung Cancer Treatments and Mutations 6
    • COVID-19 Clinical Research Studies 11

Cheng‐Yi Wang

85 papers receiving 2.6k citations

Hit Papers

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths 2020 · 624 citations
6242020202620222024200400600

Peers

Cheng‐Yi Wang
Comparison fields: 5 of 155
  • Infectious Diseases 1.0k
  • Applied Microbiology and Biotechnology 107
  • Modeling and Simulation 178
  • General Dentistry 44
  • Critical Care and Intensive Care Medicine 117
Replace Antonino Giarratano with:
Antonino Giarratano Italy
Su Jin Jeong South Korea
Li Weng China
Guangcai Duan China
Fang Liu China
Yiming Li China
Qinyong Hu China
Hongliu Cai China
Cheng‐Yi Wang relative to Antonino Giarratano Italy Antonino Giarratano's profile →
Citations per field
00.5×2.9×
Antonino Giarratano · 1×
Citations per year

Countries citing papers authored by Cheng‐Yi Wang

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Yi Wang more than expected).

Fields of papers citing papers by Cheng‐Yi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Yi Wang. The network helps show where Cheng‐Yi Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheng‐Yi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheng‐Yi Wang Line = papers co-authored together Cheng‐Yi Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20231
2 20231
3 20224
4 20223
5 20216
6 202110
7 202117
8 202114
9 2020271
10 2020343
11 202071
12 20197
13 201929
14 201816
15 201722
16 201447
17 201257
18 20121
19 201217
20 19899

About Cheng‐Yi Wang

Cheng‐Yi Wang is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Critical Care and Intensive Care Medicine, Physiology and Neurology, having authored 88 papers that have together received 2.7k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Respiratory Support and Mechanisms (15 papers), COVID-19 Clinical Research Studies (11 papers), Asthma and respiratory diseases (10 papers), Long-Term Effects of COVID-19 (8 papers), Inhalation and Respiratory Drug Delivery (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Obstructive Sleep Apnea Research (5 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Applied Microbiology and Biotechnology (107 citations), Modeling and Simulation (178 citations), General Dentistry (44 citations) and Critical Care and Intensive Care Medicine (117 citations). Cheng‐Yi Wang has collaborated with scholars based in Taiwan, United States and Netherlands. Frequent co-authors include Po‐Ren Hsueh, Chih-Cheng Lai, Chih‐Cheng Lai, Wen‐Chien Ko, Ya‐Hui Wang, Yahui Wang, Chao‐Hsien Chen, Chong‐Jen Yu, Hao‐Chien Wang and Kuen‐Feng Chen. Their work appears in journals such as International Journal of COPD, Journal of Microbiology Immunology and Infection, PLoS ONE, Journal of Infection and Public Health and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026